Association of malignant insulinoma and type 2 diabetes mellitus: A case report

Annales d'Endocrinologie

Volumn 69, Issue 1, 2008, Pages 69-72

  Schmitt, J ^a   Boullu Sanchis, S ^a   Moreau, F ^a   Drui, S ^b   Louis, B ^c   Chabrier, G ^a   Pinget, M ^a   Jeandidier, N ^a  

^a HÔPITAL CIVIL   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c clinique Sainte Odile   (France)

Author keywords

Diazoxide toxicity; Malignant insulinoma; Type 2 diabetes

Indexed keywords

ANGIOPEPTIN; C PEPTIDE; CHROMOGRANIN A; DIAZOXIDE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; PROINSULIN;

AGED; ARTICLE; BODY MASS; CASE REPORT; CHEMOEMBOLIZATION; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DYSPNEA; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; HYPONATREMIA; INSULIN BLOOD LEVEL; INSULINOMA; KIDNEY FAILURE; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER FAILURE; LIVER SCINTISCANNING; NON INSULIN DEPENDENT DIABETES MELLITUS; OSMOLARITY; PANCREAS SCINTISCANNING; PROGNOSIS; RARE DISEASE; RECURRENT DISEASE; STAINING; SURVIVAL; TREATMENT RESPONSE;

AGED; ANTIHYPERTENSIVE AGENTS; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; HYPOGLYCEMIA; INSULIN; INSULINOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41549122466     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2007.11.002     Document Type: Article

References (14)

1. Hirshberg B., Cochran C., Skarulis M.C., et al. Malignant insulinoma: spectrum of unusual clinical features. Cancer 104 (2005) 264-272
2. Romeo S., Millione M., Gatti A., et al. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2. Horm Res 65 (2006) 120-125
3. Ravnik-Oblak M., Janez A., and Kocijanicic A. Insulinoma induced hypoglycemia in a type 2 diabetic patient. Wien Klin Wochenschr 113 (2001) 339-341
4. Sakurai A., Aizawa T., Katakura M., et al. Insulinoma in a patient with non-insulin-dependent diabetes mellitus. Endocr J 44 (1997) 473-477
5. Grunberger G. Insulin resistance in a case of coexsisting insulinoma and type 2 diabetes. Acta Diabetol 30 (1993) 243-250
6. Nagai T., Imamura M., Takai Y., and Mori M. Insulinoma accompanied by diabetes mellitus. Diabetes Res Clin Pract 60 (2003) 19-23
7. Kane L.A., Grant C.S., Noppoldt T.B., and Service F.J. Insulinoma in a patient with NIDDM. Diabetes care 16 (1993) 1298-1300
8. Lei W., Wang T., Chen T., Chang W., Yang T., and Wang C. Insulinoma causing hypoglycemia in a patient with type 2 diabetes. J Formos Med Assoc 106 (2007) 392-396
9. Svartberg J., Stridsberg M., Wilander E., Andersson D.E.H., and Eriksson B. Tumour-induced hypoglycaemia in a patient with insulin-dependent diabetes mellitus. J Int Med 239 (1996) 181-185
10. Priestly J.T. Hyperinsulinism. Ann R Coll Surg Engl 31 (1962) 211-227
11. Silvani P., Camporesi A., Mandelli A., et al. A case of severe diazoxide toxicity. Paediatr Anaesth 14 (2004) 607-609
12. Abu-Osba Y.K., Manasra K.B., and Mathew P.M. Complications of diazoxide treatment in persistant neonatal hyperinsulinism. Arch Dis Child 64 (1989) 1496-1500
13. Schutt M., Lorch H., Kruger S., et al. Recurrent hypoglycemia caused by malignant insulinoma: chemoembolization as a therapeutic option. Med Klin 96 (2001) 632-636
14. Ruszieniswski P., and Malka D. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors. Digestion 62 (2000) 79-83